Open access
1,747
Views
72
CrossRef citations to date
0
Altmetric
Perspective
Have we overestimated the benefit of human(ized) antibodies?
Daniel R. Getts Tolera Therapeutics Inc.; Kalamazoo, MI USA
Correspondence[email protected]
, Meghann T. Getts DeGetts Consulting & Project Management; Kalamazoo, MI USA
, Derrick P. McCarthy Department of Microbiology-Immunology
Feinberg School of Medicine; Northwestern University; Chicago, IL USA
, Emily ML Chastain Tolera Therapeutics Inc.; Kalamazoo, MI USA
& Stephen D. Miller Department of Microbiology-Immunology Feinberg School of Medicine; Northwestern University; Chicago, IL USA
Pages 682-694
|
Received 27 Sep 2010, Accepted 13 Sep 2010, Published online: 01 Nov 2010
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.